Welcome to Active Fine Chemical
AFCL was established with a vision to serve the health care sector of 
Bangladesh with innovative products and services. AFCL is slowly but surely emerging as an original RND-driven organization in Bangladesh. We are the first company in Bangladesh to apply for a patent for an original therapeutic molecule.
Message from Managing Director
2016 has brought in a new horizon for Pharma sector of Bangladesh. Two of the major pharma manufacturers of Bangladesh have received US FDA approval to sell their products in USA., perhaps one of the most lucrative markets of the world. This event has brought in a new dimesion in the pharmaceutical arena. All the big pharma manufacturers are now preparing to apply for US FDA. Also they are under market pressure to keep their brand value up to the mark with the US FDA approved companies. Pharmaceutical scenario of Bangladesh is fast changing in favor of regulated plants. One of the challenges of US FDA and other regulated market’s license is to source raw materials from audit approved factories. Audit approved by regulated bodies of USA and Europe. The policy requires the manufacturers to purchase APIs and other critical raw materials from audited factories. Hence, we are seeing new behavioral pattern in purchases. We have to upgrade our plant to meet standards Europe or USA. Hence, we need to plan now to stay competitive in the near future. Our cephalosporin products has not seen significant sales yet due to new policies set by our customers to d long term stability tests at least for 18 months. Hence we are yet to see significant sales from this plant. We are expecting a good turn over from this plant once the manufacturers approve our cephalosporin products. We have also constructing oncological API manufacturing unit. Oncology formulation plant is also under construction. Our associated concern AFC Health has signed agreement with American Oncology Institute to build three world class Cancer hospitals in Bangladesh. These will help us tremendously to take off in oncology related products. To faceoff incoming strong competition from new local manufacturers in coming years we have planned to build stronger and deep relationship with our customers by investing into forward end of the healthcare sector. I am cautiously optimistic about our next five years as we move forward. In this arduous journey we seek your kind cooperation and blessings. May Allah keep us all safe and prosperous.
